SUBSTITUTED-3-SULFONYLINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
摘要
<p num="1"><br/><br/><br/>The present invention provides a compound of formula (I) and the use thereof <br/>for the treatment of a central nervous system disorder related to or affected <br/>by the 5-HT6 receptor.<br/>
申请公布号
CA2619010(A1)
申请公布日期
2007.02.22
申请号
CA20062619010
申请日期
2006.08.08
申请人
WYETH
发明人
MCDEVITT, ROBERT EMMETT;MCFARLANE, GERALDINE RUTH;LIU, KEVIN;ROBICHAUD, ALBERT JEAN;BERNOTAS, RONALD CHARLES;LI, YANFANG;GROSANU, CRISTINA;LO, JENNIFER REBECCA;ELOKDAH, HASSAN MAHMOUD;GREENFIELD, ALEXANDER ALEXEI
